Selected
Type of publications
Regions
Diseases
Vaccine topics
Target population
Methodological quality (AMSTAR 2)
Publication date
2534 results found
2023 ∙ Yasmin, F. Najeeb, H. Naeem, U. Moeed, A. Atif, A. R. Asghar, M. S. Nimri, N. Saleem, M. Bandyopadhyay, D. Krittanawong, C. Fadelallah Eljack, M. M. Tahir, M. J. Waqar, F.
Adverse events following COVID-19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia
  • Vaccine/vaccination
  • All age groups
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Zhang, H. Q. Cao, B. Z. Cao, Q. T. Hun, M. Cao, L. Zhao, M. Y.
An analysis of reported cases of hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Bachour, Y.
An update and overview of the literature on late inflammatory reactions (LIRs) in soft tissue fillers after SARS-CoV-2 infection and vaccination
  • Vaccine/vaccination
  • All age groups
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Thammathiwat, T. Banjongjit, A. Iampenkhae, K. Townamchai, N. Kanjanabuch, T.
ANCA Associated Glomerulonephritis Following SARS-CoV-2 Vaccination: A Case Series and Systematic Review
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Dimitroglou, Margarita Sokou, Rozeta Iacovidou, Nicoletta Pouliakis, Abraham Kafalidis, Georgios Boutsikou, Theodora Iliodromiti, Zoi
Anti-SARS-CoV-2 Immunoglobulins in Human Milk after Coronavirus Disease or Vaccination-Time Frame and Duration of Detection in Human Milk and Factors That Affect Their Titers: A Systematic Review
  • Vaccine/vaccination
  • Pregnant women
  • COVID-19
  • Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Roslan, M. Mohd Nisfu, F. R. Arzmi, M. H. Abdul Wahab, R. Zainuddin, N.
Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 Messenger Ribonucleic Acid Vaccines in Infected Individuals: A Systematic Review
  • Vaccine/vaccination
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Roslan, M. Nisfu, F. R. M. Arzmi, M. H. Wahab, R. A. Zainuddin, N.
Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 Messenger Ribonucleic Acid Vaccines in Infected Individuals: A Systematic Review
  • Vaccine/vaccination
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Domado, A. M. Adaza, H. J. F. Beltran, Apnc Buenviaje, L. M. Co, C. D. Combalicer, L. R. Corona, S. M. A. Cruz, J. B. F. Dinjotian, Macg Esperanzate, E. M. S. Luna, S. R. G. Pascua, E. J. R. Vicencio, R. R. T. Reyes, S. N.
Antibody titers of individuals vaccinated for COVID-19: A systematic review
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Fleszar-Pavlovic, Sara E. Cameron, Linda D.
Are Interventions Efficacious at Increasing Human Papillomavirus Vaccinations Among Adults? A Meta-Analysis
  • Adults
  • Human papillomavirus (HPV)
  • Acceptance
  • Coverage
Rating:
Not applicable
2023 ∙ Hoang, T. N. A. Quach, H. L. Hoang, V. N. Tran, V. T. Pham, Q. T. Vogt, F.
Assessing the robustness of COVID-19 vaccine efficacy trials: systematic review and meta-analysis, January 2023
  • Vaccine/vaccination
  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Rating:
Critically low